Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 5
2003 4
2004 6
2005 3
2006 5
2007 4
2008 2
2009 3
2010 8
2011 8
2012 5
2013 5
2014 3
2015 2
2016 3
2017 4
2018 2
2019 3
2020 1
2021 4
2022 4
2023 7
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
EN-DALBACEN 2.0 Cohort: real-life study of dalbavancin as sequential/consolidation therapy in patients with infective endocarditis due to Gram-positive cocci.
Hidalgo-Tenorio C, Sadyrbaeva-Dolgova S, Enríquez-Gómez A, Muñoz P, Plata-Ciezar A, Miró JM, Alarcón A, Martínez-Marcos FJ, Loeches B, Escrihuela-Vidal F, Vinuesa D, Herrero C, Boix-Palop L, Del Mar Arenas M, Vázquez EG, de Las Revillas FA, Pasquau J; EN-DALBACEN study group. Hidalgo-Tenorio C, et al. Among authors: herrero c. Int J Antimicrob Agents. 2023 Sep;62(3):106918. doi: 10.1016/j.ijantimicag.2023.106918. Epub 2023 Jul 11. Int J Antimicrob Agents. 2023. PMID: 37442488 Free article.
Universal evaluation of MLC models in treatment planning systems based on a common set of dynamic tests.
Saez J, Bar-Deroma R, Bogaert E, Cayez R, Chow T, Clark CH, Esposito M, Feygelman V, Monti AF, Garcia-Miguel J, Gershkevitsh E, Goossens J, Herrero C, Hussein M, Khamphan C, Kierkels RGJ, Lechner W, Lemire M, Nevelsky A, Nguyen D, Paganini L, Pasler M, Fernando Pérez Azorín J, Ramos Garcia LI, Russo S, Shakeshaft J, Vieillevigne L, Hernandez V. Saez J, et al. Among authors: herrero c. Radiother Oncol. 2023 Sep;186:109775. doi: 10.1016/j.radonc.2023.109775. Epub 2023 Jun 28. Radiother Oncol. 2023. PMID: 37385376 Free article.
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
A 6-mRNA host response classifier in whole blood predicts outcomes in COVID-19 and other acute viral infections.
Buturovic L, Zheng H, Tang B, Lai K, Kuan WS, Gillett M, Santram R, Shojaei M, Almansa R, Nieto JÁ, Muñoz S, Herrero C, Antonakos N, Koufargyris P, Kontogiorgi M, Damoraki G, Liesenfeld O, Wacker J, Midic U, Luethy R, Rawling D, Remmel M, Coyle S, Liu YE, Rao AM, Dermadi D, Toh J, Jones LM, Donato M, Khatri P, Giamarellos-Bourboulis EJ, Sweeney TE. Buturovic L, et al. Among authors: herrero c. Sci Rep. 2022 Jan 18;12(1):889. doi: 10.1038/s41598-021-04509-9. Sci Rep. 2022. PMID: 35042868 Free PMC article. Clinical Trial.
82 results